Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study
Jue‐Sheng Ong(QIMR Berghofer Medical Research Institute), Joseph L. Kelley(Magee-Womens Hospital), Ingo B. Runnebaum, Puya Gharahkhani(Queensland University of Technology), Stefanie Burghaus, Liang‐Dar Hwang(The University of Queensland), Ralf Bützow(Helsinki University Hospital), Nicholas G. Martin(University of Wollongong), Natalia Bogdanova(Medizinische Hochschule Hannover), Penelope M. Webb(QIMR Berghofer Medical Research Institute), Peter A. Fasching(Universitätsklinikum Erlangen), Cristina Rodríguez‐Antona(Instituto de Salud Carlos III), Marilyn C. Cornelis(Northwestern University), Thilo Dörk(Hannover Re (Germany)), Michael E. Jones(Institute of Cancer Research), Anthony J. Swerdlow(Institute of Cancer Research), Drakoulis Yannoukakos(National Centre of Scientific Research "Demokritos"), Stuart MacGregor(The University of Queensland), Marc T. Goodman(Cedars-Sinai Medical Center), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Matthias W. Beckmann(Universitätsklinikum Erlangen), Liisa M. Pelttari(University of Helsinki), James D. Brenton(Cambridge University Hospitals NHS Foundation Trust), Javier Benı́tez(Spanish National Cancer Research Centre), Ignace Vergote(KU Leuven), Renée T. Fortner(Norwegian Institute of Public Health), Heli Nevanlinna(University of Helsinki), Gabriel Cuéllar-Partida(23andMe (United States)), Elio Ríboli(Imperial College London), Adriaan Vanderstichele, Matthias Duerst, Diether Lambrechts(VIB-KU Leuven Center for Cancer Biology), Els Van Nieuwenhuysen, Alexander Hein, Enda Bryne, Shan Wang‐Gohrke(Universität Ulm), Michael C. Quinn(New South Wales Department of Health), Natalia Antonenkova(N.N. Alexandrov National Cancer Centre), Jenny Chang‐Claude(Universität Hamburg), Mary Anne Rossing(Fred Hutch Cancer Center), Digna Velez Edwards, Ursula Eilber(University of Helsinki), Robert P. Edwards(Magee-Womens Research Institute), Peter Hillemanns(Medizinische Hochschule Hannover), Maria J. García, Minouk J. Schoemaker(Institute of Cancer Research)
Cited by 21
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
|Choice Reviews Online|2008|5.4k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k